Clinical Trial Update: Study of Acthar® Gel (Acthar) for Amyotrophic Lateral Sclerosis (ALS) [Phase 2, Phase 3]

View source ↗

Summary

A study update for Acthar Gel in amyotrophic lateral sclerosis (ALS) shows the trial was terminated with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Acthar Gel (repository corticotropin injection)

Snippet

Sponsor: Mallinckrodt | Conditions: Amyotrophic Lateral Sclerosis | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2020-09-03